[Long-term survival of a patient with hepatocellular carcinoma with portal vein tumor thrombus treated with interferon-α and 5-fluorouracil combination therapy].

Yujiro Tsuda, Shogo Kobayashi, Yoshito Tomimaru, Hirofumi Akita, Naoki Hama, Hiroshi Wada, Koichi Kawamoto, Hidetoshi Eguchi, Koji Umeshita, Yuichiro Doki, Masaki Mori, Hiroaki Nagano

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We report a case of long-term survival of a patient with hepatocellular carcinoma( HCC) with portal vein tumor thrombus (PVTT) treated with fluorouracil arterial infusion and interferon therapy (FAIT). A 54-year-old man with severe liver cirrhosis was diagnosed as having HCC in segment 1 and 4 of the liver, with PVTT in the left branch. After 7 courses of FAIT, the main tumor and PVTT were no longer visible on enhanced computed tomography scans. However, recurrent HCC was detected in segment 4. Subsequently, the patient was treated with transarterial chemoembolization (TACE) after confirmation of portal blood flow. At 5 years after the initial treatment, the patient is alive without further recurrence of HCC. Therefore, even if patients have HCC with PVTT in the main branch and severe liver cirrhosis, long-term survival is possible by administration of a combination of FAIT and TACE.

Original languageEnglish
Pages (from-to)1804-1806
Number of pages3
JournalUnknown Journal
Volume40
Issue number12
Publication statusPublished - Nov 2013

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of '[Long-term survival of a patient with hepatocellular carcinoma with portal vein tumor thrombus treated with interferon-α and 5-fluorouracil combination therapy].'. Together they form a unique fingerprint.

  • Cite this

    Tsuda, Y., Kobayashi, S., Tomimaru, Y., Akita, H., Hama, N., Wada, H., Kawamoto, K., Eguchi, H., Umeshita, K., Doki, Y., Mori, M., & Nagano, H. (2013). [Long-term survival of a patient with hepatocellular carcinoma with portal vein tumor thrombus treated with interferon-α and 5-fluorouracil combination therapy]. Unknown Journal, 40(12), 1804-1806.